Cao, Xuezhi
Liang, Yong
Hu, Zhenxiang
Li, Huiyu http://orcid.org/0000-0002-1977-3981
Yang, Jiaming
Hsu, Eric J. http://orcid.org/0000-0002-6743-2399
Zhu, Jiankun
Zhou, Jin
Fu, Yang-Xin http://orcid.org/0000-0001-8441-6617
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP180725, RR150072)
Article History
Received: 24 June 2021
Accepted: 14 September 2021
First Online: 7 October 2021
Competing interests
: The authors declare the following competing interests: Dr. Yang-Xin Fu and Xuezhi Cao are co-inventors on a US provisional patent “Interferon prodrug for the treatment of cancer”, application Ser. No. 62/522,564, which incorporates discoveries described in this manuscript. The patent application was filed by The Board Of Regents Of The University Of Texas System. Zhenxiang Hu and Jiaming Yang are the employees of Livzon. Other authors declare no competing interests.